BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

NewEdge Advisors, LLC's Holding History (CIK: 0001633516)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 50,041 Value ($000) $390 Avg Close $7.23 Range $6.00 - $8.17
Q1 2025
Shares 11 Value ($000) $0 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 11 Value ($000) $0 Avg Close $7.59 Range $6.85 - $8.44
Q3 2023
Shares 30 Value ($000) $0 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 30 Value ($000) $0 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 4,108 Value ($000) $34 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 8,325 Value ($000) $0 Avg Close $12.47 Range $10.36 - $14.50
Q1 2022
Shares 11,495 Value ($000) $187 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 12,618 Value ($000) $175 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 14,255 Value ($000) $205 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 12,291 Value ($000) $194 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 12,406 Value ($000) $126 Avg Close $10.31 Range $7.27 - $14.24
Q3 2020
Shares 24,000 Value ($000) $82 Avg Close $4.29 Range $3.30 - $6.03